Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Vivo Opportunity, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Exercised (in-or-at-the-money) 5,215,000 options to buy @ $2.5, valued at $13M
09/28/2023 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Exercised (in-or-at-the-money) 3,203,093 options to buy @ $1.75, valued at $5.6M
08/10/2023 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.
Txns: Bought 3,157,894 shares @ $1.9, valued at $6M
Bought 3,157,894 warrants @ $2.47, valued at $7.8M
05/15/2023 3 Vivo Opportunity, LLC (10% Owner) has filed a Form 3 on SOLENO THERAPEUTICS INC
09/08/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.
Txns: Bought 600,000 shares @ $3.6, valued at $2.2M
09/08/2022 SC 13G Vivo Opportunity, LLC reports a 7.1% stake in Astria Therapeutics, Inc.
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 SC 13G Vivo Opportunity, LLC reports a 5.9% stake in Geron Corporation
02/11/2022 SC 13G/A Vivo Opportunity, LLC reports a 4.1% stake in Avadel Pharmaceuticals plc
01/31/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 800,000 shares @ $27, valued at $21.6M
01/28/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Exercised (in-or-at-the-money) 75,749 options to buy @ $13.2, valued at $999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy @ $13.2, valued at $19.2M
Exercised (in-or-at-the-money) 324,740 options to buy @ $13.2, valued at $4.3M
09/30/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2021 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Converted 944,056 shares @ $0
Converted 472,296 shares @ $0
Sold 62 shares @ $20, valued at $1.2k
Converted 1,092,080 shares @ $0
Converted 317,922 shares @ $0
Converted 345,568 shares @ $0
Sold 144 shares @ $20, valued at $2.9k
Bought 175,733 shares @ $20, valued at $3.5M
Converted 150,802 shares @ $0
Converted 43,901 shares @ $0
Converted 47,718 shares @ $0
02/09/2021 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.
Txns: Converted 1,933,185 shares @ $0
Converted 266,948 shares @ $0
Bought 103,372 shares @ $17, valued at $1.8M
Bought 14,275 shares @ $17, valued at $242.7k
Bought 357,353 shares @ $17, valued at $6.1M
Converted 713,203 preferred shares @ $0
Converted 98,484 preferred shares @ $0
Converted 364,138 preferred shares @ $0
Converted 50,282 preferred shares @ $0
07/21/2020 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Bought 789,474 shares @ $19, valued at $15M
Converted 3,245,048 shares @ $0
Bought 185,526 shares @ $19, valued at $3.5M
Converted 3,158,851 convertible preferred @ $0
03/11/2020 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 347 shares @ $19.5, valued at $6.8k
Sold 48 shares @ $19.5, valued at $936
Sold 133 shares @ $19.5, valued at $2.6k
03/11/2020 SC 13G Vivo Opportunity, LLC reports a 4.8% stake in Verastem, Inc.
03/04/2020 SC 13G Vivo Opportunity, LLC reports a 6.2% stake in Avadel Pharmaceuticals plc
02/13/2020 SC 13G/A Vivo Opportunity, LLC reports a 0% stake in Acer Therapeutics Inc.
02/13/2020 SC 13G/A Vivo Opportunity, LLC reports a 10% stake in MEI Pharma, Inc.
02/13/2020 SC 13G/A Vivo Opportunity, LLC reports a 2.9% stake in Xenon Pharmaceuticals Inc.
02/11/2020 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 1,134 shares @ $22, valued at $24.9k
Sold 157 shares @ $22, valued at $3.5k
Sold 4,614 shares @ $22, valued at $101.5k
Sold 1,451 shares @ $21.4, valued at $31.1k
Sold 200 shares @ $21.4, valued at $4.3k
Sold 5,904 shares @ $21.4, valued at $126.3k
02/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2020 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 2,673 shares @ $22.2, valued at $59.3k
Sold 369 shares @ $22.2, valued at $8.2k
Sold 10,878 shares @ $22.2, valued at $241.5k
Sold 1,459 shares @ $22.1, valued at $32.2k
Sold 201 shares @ $22.1, valued at $4.4k
Sold 5,940 shares @ $22.1, valued at $131.3k
Sold 1,037 shares @ $21.7, valued at $22.5k
Sold 143 shares @ $21.7, valued at $3.1k
Sold 4,220 shares @ $21.7, valued at $91.6k
01/31/2020 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Converted 75,759 shares @ $0
Converted 1,455,576 shares @ $0
Converted 324,783 shares @ $0
Converted 1,000 options to buy @ $0
Converted 19,213 options to buy @ $0
Converted 4,287 options to buy @ $0
12/02/2019 3 Vivo Opportunity, LLC (10% Owner) has filed a Form 3 on Sierra Oncology, Inc.
11/25/2019 SC 13G Vivo Opportunity, LLC reports a 15.1% stake in Sierra Oncology, Inc.
04/12/2019 SC 13G Vivo Opportunity, LLC reports a 5.8% stake in Chiasma, Inc.
03/26/2019 SC 13G Vivo Opportunity, LLC reports a 4.8% stake in Matinas BioPharma Holdings, Inc.
03/25/2019 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 292,609 shares @ $22.25, valued at $6.5M
Sold 40,407 shares @ $22.25, valued at $899.1k
Sold 83,984 shares @ $22.25, valued at $1.9M
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy